Ellume
Founded Year
2010Stage
Asset Sale | AssetsPurchasedTotal Raised
$33.43MAbout Ellume
Ellume develops a range of diagnostic tests for common infectious diseases and designs products which include home influenza tests, digital devices for clinics, and developing products for health crises tailored specifically for both the product user and the disease state. The company was founded in 2010 and is based in East Brisbane, Australia.
Missing: Ellume's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Ellume's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Ellume
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Ellume is included in 5 Expert Collections, including Medical Devices.
Medical Devices
8,845 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
4,342 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Digital Health
13,119 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Telehealth
2,856 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Health IT
8,881 items
Ellume Patents
Ellume has filed 20 patents.
The 3 most popular patent topics include:
- Molecular biology
- Analytical chemistry
- Immunologic tests
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/31/2020 | 9/13/2022 | Spectroscopy, Microscopy, Molecular biology, Analytical chemistry, Fluorescence | Grant |
Application Date | 1/31/2020 |
|---|---|
Grant Date | 9/13/2022 |
Title | |
Related Topics | Spectroscopy, Microscopy, Molecular biology, Analytical chemistry, Fluorescence |
Status | Grant |
Latest Ellume News
Jan 16, 2023
Creditors of Brisbane-based infectious disease testing products developer Ellume have agreed to a US$38 million ($57 million) deal that will see the business, known for its rapid COVID-19 test, enter the hands of competitor Hough Consolidated. The funds will be paid to creditors and noteholders after a vote in favour of the Deed of Co...
Ellume Frequently Asked Questions (FAQ)
When was Ellume founded?
Ellume was founded in 2010.
Where is Ellume's headquarters?
Ellume's headquarters is located at 57 Didsbury Street, East Brisbane.
What is Ellume's latest funding round?
Ellume's latest funding round is Asset Sale.
How much did Ellume raise?
Ellume raised a total of $33.43M.
Who are the investors of Ellume?
Investors of Ellume include Hough Pharma and National Institutes of Health.
Who are Ellume's competitors?
Competitors of Ellume include Visby Medical, Baebies, Cardea Bio, MeMed, Accellix, Inflammatix, Oxford Nanopore Technologies, LumiraDx, Cue Health, Lumos Diagnostics and 22 more.
Compare Ellume to Competitors
Inflammatix is a molecular diagnostics company that develops rapid tests that read the immune system to resolve major clinical and public health challenges. The company's initial focus is on acute bacterial, viral infections, and sepsis.
Torus Biosystems develops a syndromic diagnostic device designed for use in testing DNA for scientific and medical research purposes. Its Torus Synestia System provides seamless, comprehensive, sample-to-insight test results for major infectious diseases in a faster format than conventional methods, helping for better patient care and improved outcomes. The company was founded in 2019 and is based in Cambridge, Massachusetts.
Sight Diagnostics provides affordable and accurate diagnostics in a compact platform designed for use in qualified labs in low volume settings. Its proprietary machine-vision based technology provides the capability to perform multiple tests on a single, easy-to-operate platform.
Weavr Health is dedicated to connecting people to health by simplifying sample collection and processing for healthcare. The Velvet device is designed so anyone, anywhere can easily collect high-quality samples without a phlebotomist. The Velvet device offers a smooth experience of blood self-collection for patients. It leverages a similar experience to traditional glucose testing, which >25% of people have experienced. Each device arrives with all that is needed to collect, package and ship quality samples to the lab for a convenient experience.
Binx Health is an in vitro diagnostics Point-of-Care (POC) company that provides at-home STI testing. The platform also includes evidence-based testing, counseling, treatment, and follow up in order to increase screening and reduce infections.
Baebies developed a nimble bioassay automation platform to rapidly perform multiplex enzymatic assays and other tests. The company licensed its core technology, digital microfluidics, from Illumina. In addition to a technology license in newborn screening that does not include sequencing, Baebies also received equipment, contracts, and other consideration in exchange for a share of ownership in the new company. The company was founded in 2013 and is based in Durham, North Carolina.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.